1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Advanced Solid Malignancies: new trials by email Literature Review of Advanced Solid Malignancies trials Research Report on Advanced Solid Malignancies
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Open-Label, Multi-Centre, Study to Assess the Safety of Fixed-Dose Durvalumab + Tremelimumab Combination Therapy or Durvalumab Monotherapy in Advanced Solid Malignancies. MEDI4736 (Durvalumab), MEDI4736 (Durvalumab) + Tremelimumab - Advanced Solid Malignancies | Phase 3 | Completed | AstraZeneca | 867 | 2017-06-05 | 2022-12-22 |
Diabetes Mellitus, Insulin-Dependent, 12 (1)
durvalumab (1) · tremelimumab (1)
AstraZeneca (1)
Canada (1) · France (1) · Germany (1) · Italy (1) · Netherlands (1) · South Korea (1) · United Kingdom (1) · United States (1)